Dr. Mark Andrew Melrose, DO

  • New York, NY
  • Emergency medicine physician
NPI1861492985PAC ID5597750638
Medicare services, 2024
399
Medicare patients, 2024
410
Part D claims, 2024
60
MIPS score, 2024
79
Hospital affiliations
1
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

See all 5 affiliations

Find Dr. Melrose's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark Andrew Melrose is an emergency medicine physician in New York, New York

Dr. Melrose practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Melrose's NPI, 1861492985, was assigned on July 29, 2005. Dr. Melrose graduated from Philadelphia College of Osteopathic Medicine in 1984. Dr. Melrose holds New York license 174682.

NPI and contact details
Medicare PAC ID
5597750638
NPI enumeration date
July 29, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
68
Medical school graduation
1984

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mark Andrew Melrose practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Melrose's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Source: Dmand AI Affiliation Data

Dr. Mark Andrew Melrose is affiliated with 1 site of care and 4 medical groups

Dr. Melrose's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Emergency Physician Associates of North Jersey. Dmand AI also links Dr. Melrose to 3 more medical groups, each named with a free account.

See all 5 affiliations for Dr. Melrose

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mark Andrew Melrose's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melrose practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account
+3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Melrose practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark Andrew Melrose is one of 3,709 emergency medicine physicians in New York

Emergency medicine is Dr. Melrose's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Melrose's licenses on file in 2 states: New York and New Jersey.

Specialties and state licenses

  • Emergency medicine, New YorkPrimaryLicense 174682 · taxonomy 207P00000X
  • New Jersey licenseLicense 25MB04846900

Emergency medicine physicians near Dr. Melrose

Counts of emergency medicine physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark Andrew Melrose billed Medicare for 399 services in 2024

CMS data shows 399 Medicare services from Dr. Melrose across 4 procedure codes in 2024, for 410 Medicare patients. Medicare paid $54,310 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024399
Medicare patients410
Paid by Medicare$54,310
Procedure codes4

Dr. Melrose's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 4562024: 39913%

Dr. Melrose compared with the New York median for emergency medicine physicians, 2024

  • Dr. Melrose
  • New York median
Medicare services
399vs 21982% above
Medicare patients
410vs 21690% above

Medians across 3,510 emergency medicine physicians in New York with Dmand AI profiles that report each measure.

Dr. Melrose's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Melrose

Need commercial claims for Dr. Melrose?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Melrose and other emergency medicine physicians in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mark Andrew Melrose treated 410 Medicare patients in 2024, average age 75

CMS counts 410 Medicare patients who saw Dr. Melrose in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Melrose's median patient age at 68, with 54% women.

Medicare patients, 2024410
Average age75
Average risk score3.26
Also on Medicaid22%

Dr. Melrose's Medicare patients by age, 2024

Dr. Melrose's Medicare patients by sex, 2024

  • Women21753%
  • Men19347%

Chronic conditions among Dr. Melrose's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer62%
  4. Arthritis53%
  5. Anxiety48%
  6. Ischemic heart disease41%
  7. Mood disorders41%
  8. Diabetes40%

Share of Medicare patients with each condition. A patient can have several.

Dr. Melrose's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women54%
  • Men45%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mark Andrew Melrose wrote 60 Medicare Part D claims in 2024

In 2024, Dr. Melrose wrote 60 Medicare Part D claims for 45 patients. 97% of them were for generic drugs.

Part D claims, 202460
Part D patients45

Dr. Melrose's Part D claims by kind of drug, 2024

  • Generic58 claims97%
  • Brand-name and other2 claims3%

Drug classes CMS tracks in Dr. Melrose's Part D claims, 2024

  • Opioids20%12 of 60 claims
  • Antibiotics43%26 of 60 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Source: Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mark Andrew Melrose scored 79 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Melrose for performance year 2024, reported as part of a group. Dr. Melrose accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Melrose's MIPS scores, performance year 2024

  • 79of 100Final score
  • 61.4of 100Quality
  • 40of 100Improvement Activities
  • 80of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find emergency medicine physicians like Dr. Melrose by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mark Andrew Melrose received $140 in industry payments in 2017

CMS Open Payments shows 1 general payment to Dr. Melrose from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Nuvectra Corporation paid the most, $140.

Companies that paid Dr. Melrose the most, 2017 to 2017

Share is of all general payments to this clinician.

See all payments to Dr. Melrose

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mark Andrew Melrose graduated from Philadelphia College of Osteopathic Medicine

Dr. Melrose graduated from Philadelphia College of Osteopathic Medicine in 1984.

  1. Medical schoolPhiladelphia College of Osteopathic Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Mark Andrew Melrose's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark Andrew Melrose

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark Andrew Melrose's NPI number?

Dr. Mark Andrew Melrose's NPI number is 1861492985. It was assigned on July 29, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark Andrew Melrose?

Dr. Mark Andrew Melrose is an emergency medicine physician in New York, New York. The primary specialty in the NPI Registry is Emergency Medicine Physician (taxonomy code 207P00000X).

Where does Dr. Mark Andrew Melrose practice?

Dr. Melrose practices at 1275 York Avenue, New York, NY 10065. Dr. Melrose's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Melrose to 3 medical groups.

What is Dr. Mark Andrew Melrose's medical license number?

Dr. Melrose holds New York license 174682, one of the licenses on file in 2 states.

Which states has Dr. Mark Andrew Melrose been licensed in?

Dmand AI has state licenses on file for Dr. Melrose in New York and New Jersey.

Which hospitals is Dr. Mark Andrew Melrose affiliated with?

Dr. Melrose practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. Mark Andrew Melrose part of?

Dr. Melrose is linked to Emergency Physician Associates of North Jersey. Dmand AI links Dr. Melrose to 3 more medical groups.

Does Dr. Mark Andrew Melrose accept Medicare?

Yes. CMS data shows Dr. Melrose billed Medicare for 399 services in 2024, and Dr. Melrose accepts Medicare assignment.

What is Dr. Mark Andrew Melrose's MIPS score?

Dr. Melrose's MIPS final score for performance year 2024 is 79 out of 100, reported as part of a group.

How many Medicare patients does Dr. Mark Andrew Melrose see?

CMS counts 410 Medicare patients who saw Dr. Melrose in 2024, with an average age of 75.

Show 4 more questionsShow fewer questions

What services does Dr. Mark Andrew Melrose bill to Medicare?

In 2024, Dr. Melrose's most billed Medicare services were emergency department visit (99285), emergency department visit (99284) and hospital inpatient care (99223).

Where did Dr. Mark Andrew Melrose go to medical school?

Dr. Melrose graduated from Philadelphia College of Osteopathic Medicine in 1984.

Has Dr. Mark Andrew Melrose received payments from drug or device companies?

CMS Open Payments shows $140 in general payments to Dr. Melrose from 1 company from 2017 to 2017. The largest total came from Nuvectra Corporation.

How long has Dr. Mark Andrew Melrose been practicing?

Dr. Melrose graduated from medical school in 1984, 42 years ago.

Selling to emergency medicine practices?

See emergency medicine physicians in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)